哈尔滨商业大学学报(自然科学版)
哈爾濱商業大學學報(自然科學版)
합이빈상업대학학보(자연과학판)
JOURNAL OF HARBIN UNIVERSITY OF COMMERCE(NATURAL SCIENCES EDITION)
2014年
2期
133-137
,共5页
李爽%吕邵娃%李永吉%杨志欣%赵义军
李爽%呂邵娃%李永吉%楊誌訢%趙義軍
리상%려소왜%리영길%양지흔%조의군
丁香苦苷%丁香苦苷-PLGA纳米粒%药动学%高效液相色谱法
丁香苦苷%丁香苦苷-PLGA納米粒%藥動學%高效液相色譜法
정향고감%정향고감-PLGA납미립%약동학%고효액상색보법
syringopicroside%syringopicroside polylactic -co -glycolic acid -nanoparti-cles%pharmacokinetics%HPLC
测定大鼠血浆中含丁香苦苷的量,并对具有抗乙肝病毒的丁香苦苷单体和丁香苦苷PLGA纳米粒进行大鼠体内药动学比较研究.采用色谱柱:Diamonsil C18(5μm,250×4.6 mm)流动相为甲醇-水(50∶50,V/V);流速为1.0 mL/min;检测波长为221 nm;进样量为20μL.测定Wistar大鼠尾静脉注射丁香苦苷后不同时间血浆中的药物质量浓度.给药剂量相同(10 mg/mL )时,丁香苦苷PLGA溶液的T1/2α和T1/2β值是丁香苦苷溶液的1.23倍和2.25倍.AUC值是丁香苦苷溶液的3.09倍,血浆清除率约为丁香苦苷溶液的1/3.经过数据拟合发现丁香苦苷单体与丁香苦苷PLGA纳米粒在大鼠体内过程均符合二室模型,载药纳米粒给药后,使丁香苦苷能在体内较长时间维持较高的血药质量浓度,起到一定的缓释作用.
測定大鼠血漿中含丁香苦苷的量,併對具有抗乙肝病毒的丁香苦苷單體和丁香苦苷PLGA納米粒進行大鼠體內藥動學比較研究.採用色譜柱:Diamonsil C18(5μm,250×4.6 mm)流動相為甲醇-水(50∶50,V/V);流速為1.0 mL/min;檢測波長為221 nm;進樣量為20μL.測定Wistar大鼠尾靜脈註射丁香苦苷後不同時間血漿中的藥物質量濃度.給藥劑量相同(10 mg/mL )時,丁香苦苷PLGA溶液的T1/2α和T1/2β值是丁香苦苷溶液的1.23倍和2.25倍.AUC值是丁香苦苷溶液的3.09倍,血漿清除率約為丁香苦苷溶液的1/3.經過數據擬閤髮現丁香苦苷單體與丁香苦苷PLGA納米粒在大鼠體內過程均符閤二室模型,載藥納米粒給藥後,使丁香苦苷能在體內較長時間維持較高的血藥質量濃度,起到一定的緩釋作用.
측정대서혈장중함정향고감적량,병대구유항을간병독적정향고감단체화정향고감PLGA납미립진행대서체내약동학비교연구.채용색보주:Diamonsil C18(5μm,250×4.6 mm)류동상위갑순-수(50∶50,V/V);류속위1.0 mL/min;검측파장위221 nm;진양량위20μL.측정Wistar대서미정맥주사정향고감후불동시간혈장중적약물질량농도.급약제량상동(10 mg/mL )시,정향고감PLGA용액적T1/2α화T1/2β치시정향고감용액적1.23배화2.25배.AUC치시정향고감용액적3.09배,혈장청제솔약위정향고감용액적1/3.경과수거의합발현정향고감단체여정향고감PLGA납미립재대서체내과정균부합이실모형,재약납미립급약후,사정향고감능재체내교장시간유지교고적혈약질량농도,기도일정적완석작용.
This paper determined the content of syringopicroside in the plasma of rats and to make a comparative study on pharmacokinetics of syringopicroside monomer with anti -HBV function and syringopicroside PLGA -nanoparticles in the vivo of rats .Chromatographic col-umn:Diamonsil C18(5 μm,250 ×4.6 mm)mobile phase: methanol-water(50∶50,V/V);flow rate:1.0 mL/min;detected wavelength:221 nm;sample amount:20 μL.The concen-tration of syringopicroside in the plasma of Wistar rats was measured at different time points after intravenous injection .The T1/2αand T1/2βvalues of syringopicroside polylactic -co-gly-colic acid-nanoparticles were 2.25 times and 1.23 times of that of the syringopicroside so-lution respectively with the same dose ( 10 mg/mL ) .The AUC value of syringopicroside polylactic-co-glycolic acid-nanoparticles was 3.09 times of that of syringopicroside solu-tion and the plasma clearance rate of syringopicroside polylactic -co-glycolic acid-nanop-articles was one third of that of syringopicroside .Through the data fitting method , it was found that both syringopicroside monomer and syringopicroside polylactic -co-glycolic acid-nanoparticles in rats conformed to the two -compartment model .The SYR-PLGA-NP changed the feature of pharmacokinetics in the body of rats by making the syringopicroside remain relatively high concentration in plasma for a longer period ,having a slow -releasing effect.